Patterns of dentate granule cell responses to perforant path stimulation in epileptic mice with granule cell dispersion.
In adult mice, intrahippocampal administration of kainic acid induces a structural modification of the granule cell layer reminiscent of granule cell dispersion (GCD) seen in humans with temporal lobe epilepsy. We tested that GCD might be involved in the patterns of granule cell responses to perforant path stimulation by recording field potentials in vivo after kainic acid-induced status epilepticus until the phase of chronic seizure activity in presence of GCD or after its alteration by K252a co-treatment, an inhibitor of tyrosine kinase activities. Stimulation triggered bursts of multiple population spikes, the number of which progressively increased with time whereas their amplitude decreased in parallel with the progressive decrease in granule cell density. The population spike threshold was reached for a lower excitatory synaptic drive than in controls, as assessed by the initial slope of the field excitatory post-synaptic potential. This indicates that, for identical synaptic responses, granule cells were closer to the firing threshold. Fast inhibition, assessed by paired pulse stimulation, was compromised immediately after the initial status epilepticus, consistent with the rapid loss of most hilar cells. Neither the epileptic course nor the epileptiform responses of the granule cells were modified and manipulation by alteration following GCD manipulation while granule cell neuropeptide-Y immunostaining was substantially decreased. In this mouse model of TLE, granule cells display a progressive increase in epileptiform responses to afferent input until the occurrence of spontaneous seizures. The population spike amplitude decreases in parallel with GCD while the granule cell excitability is enhanced. Consequently, data from field potentials in epilepsy experiments should be interpreted with care, taking into account the possible variations in the neuronal density in the recorded area.
Rougier
A
A
Laboratoire d'Epileptologie Expérimentale et Clinique, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France. alain.rougier@ar-luni.u-bordeaux2.fr
Arthaud
S
S
Zombre
N
N
La Salle
G Le Gal
Gle G
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002227:Carbazoles / Q000494:pharmacology; D002452:Cell Count / Q000379:methods; D004195:Disease Models, Animal; D004307:Dose-Response Relationship, Radiation; D004347:Drug Interactions; D004558:Electric Stimulation / Q000379:methods; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004827:Epilepsy / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D006624:Hippocampus / Q000166:cytology* / Q000473:pathology; D007150:Immunohistochemistry / Q000379:methods; D026121:Indole Alkaloids; D007608:Kainic Acid; D051379:Mice; D009474:Neurons / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D009478:Neuropeptide Y / Q000378:metabolism; D019580:Perforant Pathway / Q000187:drug effects / Q000503:physiopathology* / Q000528:radiation effects; D013194:Staining and Labeling / Q000379:methods; D013997:Time Factors
D002227:Carbazoles; D004791:Enzyme Inhibitors; D026121:Indole Alkaloids; D009478:Neuropeptide Y; C049985:staurosporine aglycone; D007608:Kainic Acid